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Abstract
Background: Descending thoracic aortic aneurysm and dissection (DTAAD) is characterized by progressive medial
degeneration, which may result from excessive tissue destruction and insufficient repair. Resistance to tissue destruction
and aortic self-repair are critical in preventing medial degeneration. The signaling pathways that control these processes in
DTAAD are poorly understood. Because Notch signaling is a critical pathway for cell survival, proliferation, and tissue repair,
we examined its activation in DTAAD.
Methods:We studied descending thoracic aortic tissue from patients with sporadic thoracic aortic aneurysm (TAA; n = 14) or
chronic thoracic aortic dissection (TAD; n = 16) and from age-matched organ donors (n = 12). Using western blot, real-time
RT-PCR, and immunofluorescence staining, we examined aortic tissue samples for the Notch ligands Delta-like 1, Delta-like 4
(DLL1/4), and Jagged1; the Notch receptor 1 (Notch1); the Notch1 intracellular domain (NICD); and Hes1, a downstream
target of Notch signaling.
Results: Western blots and RT-PCR showed higher levels of the Notch1 protein and mRNA and the NICD and Hes1 proteins
in both TAA and TAD tissues than in control tissue. However, immunofluorescence staining showed a complex pattern of
Notch signaling in the diseased tissue. The ligand DLL1/4 and Notch1 were significantly decreased and NICD and Hes1 were
rarely detected in medial vascular smooth muscle cells (VSMCs) in both TAA and TAD tissues, indicating downregulation of
Notch signaling in aortic VSMCs. Interestingly Jagged1, NICD, and Hes1 were highly present in CD34+ stem cells and Stro-1+
stem cells in aortas from TAA and TAD patients. NICD and Hes1 were also detected in most fibroblasts and macrophages
that accumulated in the aortic wall of DTAAD patients.
Conclusions: Notch signaling exhibits a complex pattern in DTAAD. The Notch pathway is impaired in medial VSMCs but
activated in stem cells, fibroblasts, and macrophages.
Citation: Zou S, Ren P, Nguyen M, Coselli JS, Shen YH, et al. (2012) Notch Signaling in Descending Thoracic Aortic Aneurysm and Dissection. PLoS ONE 7(12):
e52833. doi:10.1371/journal.pone.0052833
Editor: Ali A. Sovari, University of Illinois at Chicago, United States of America
Received September 6, 2012; Accepted November 22, 2012; Published December 26, 2012
Copyright:  2012 Zou et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by grant R01 HL085341 (to S.A.L.). The Thoracic Aortic Disease Tissue Bank at Baylor College of Medicine was supported in
part through the Tissue Banking Core of the Specialized Center of Clinically Oriented Research in Thoracic Aortic Aneurysms and Dissections (NIH P50 HL083794).
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: hyshen@bcm.edu (YHS); slemaire@bcm.edu (SAL)
Introduction
Aortic aneurysm and dissection (AAD) account for almost
11,000 deaths in the United States each year [1]. Despite
improvements in diagnostic and therapeutic techniques for
AAD, the mortality rate remains high. Characterized by aortic
medial degeneration, AAD presents as the progressive loss of
smooth muscle cells (SMCs) [2] and the destruction of extracel-
lular matrix [3]. Medial degeneration of the aorta leads to
progressive aortic dilatation, and ultimately, to dissection or
aneurysm rupture [4]. The overproduction of destructive factors
plays a significant role in aortic degeneration and AAD
development. In addition, impaired aortic protection (resistance
to tissue destruction) and insufficient aortic repair may contribute
to the process. However, the signaling mechanisms that control
aortic protection and repair in AAD are poorly understood.
Notch signaling plays an important role in regulating tissue
development and homeostasis [5,6,7] by controlling cell fate and
specifying tissue patterning [8,9,10]. The Notch signaling pathway
is activated by the binding of Delta-like or Jagged ligands to Notch
receptors, and this binding triggers the ADAM protease-mediated
cleavage of the Notch receptor extracellular domain. The
subsequent c-secretase–mediated cleavage of the Notch receptor
releases the Notch1 intracellular domain (NICD), which translo-
cates into the nucleus and regulates the expression of downstream
genes [11], such as Hes1 [12].
Specifically, Notch signaling is important in controlling vascular
smooth muscle cell (VSMC) differentiation [13,14], and the
pathway is critical to vascular development, repair, and remod-
eling [15,16,17,18]. Recently, Notch signaling has been shown to
be downregulated in human abdominal aortic aneurysm (AAA)
tissue [19] and in the ascending aorta of patients with bicuspid
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aortic valve (BAV) [20]. Furthermore, genetic variation in the
NOTCH1 gene appears to confer susceptibility to ascending aortic
aneurysm formation in patients with BAV [21]. However, Notch
signaling has not been examined in sporadic descending thoracic
aortic aneurysm and dissection (DTAAD).
Because of its important role in vascular repair and remodeling,
we hypothesize that Notch signaling may be altered in DTAAD.
In this study, we examined the activation of the Notch signaling
pathway in aortic tissue from patients with DTAAD.
Materials and Methods
Patient enrollment and tissue collection
This study protocol was approved by the institutional review
board at Baylor College of Medicine. Informed, written consent
was obtained from all patients. We enrolled patients who
underwent elective surgical repair of either a descending thoracic
aortic aneurysm without dissection (TAA) or a chronic descending
thoracic aortic dissection (TAD). We excluded patients who had
acute symptoms (,14 days); BAV; heritable connective tissue
disease (eg, Marfan syndrome); DTAAD related to trauma,
aortitis, or infection; and first-degree relatives who had TAA or
TAD. We obtained samples of aortic tissue from 30 DTAAD
patients undergoing surgical repair: TAA patients (n = 14) and
TAD patients (n = 16). In the latter group, the mean interval
between the onset of dissection and operation was 5.164.5 years.
During TAA and TAD repair, samples of the posterolateral aortic
wall were excised from the site of maximal aortic dilatation; in
cases of aortic dissection, these samples comprised the outer wall of
the false lumen. After excision, samples were rinsed with cold
saline, and any attached thrombus was removed. Control samples
(International Institute for the Advancement of Medicine, Jessup,
PA) of descending thoracic aortic tissue were obtained from 12
age-matched organ donors without aortic aneurysm, dissection,
coarctation, or previous aortic repair. For protein extraction,
tissues were snap-frozen in liquid nitrogen and stored at 280uC.
For tissue staining, samples were fixed in formalin and embedded
in paraffin. Table 1 shows the characteristics of the enrolled
subjects. Compared with control subjects, DTAAD patients were
more likely to have a history of smoking and hypertension.
Western blot
Frozen aortic tissues (approximately 100 mg) were ground and
homogenized. Protein content was extracted with RIPA buffer
(Cell Signaling Technology, Danvers, MA), and protein concen-
tration was determined by using the Bradford assay (Bio-Rad
Laboratories, Hercules, CA). A total of 20 mg protein was
electrophoretically separated in 4–20% Mini-PROTEAN TGX
Gels (Bio-Rad Laboratories) and transferred onto polyvinylidene
difluoride membranes (Bio-Rad Laboratories). Anti-Notch1 rabbit
monoclonal antibody (1:1000, Cell Signaling Technology), anti-
cleaved Notch1 rabbit monoclonal antibody (1:1000, Cell
Signaling Technology), anti-Hes1 polyclonal antibody (1:1000,
EMD Millipore, Billerica, MA), and a horseradish peroxidase-
labeled anti-rabbit secondary antibody (1:5000, Santa Cruz
Biotechnology, Santa Cruz, CA) were used to detect Notch1,
NICD, and Hes1 proteins in the extract. An anti-b-actin mouse
monoclonal antibody (1:5000; Cell Signaling Technology) was
used to confirm equal loading. Detailed information on the
primary antibodies is provided in Table 2. The western blot bands
were scanned and analyzed by using ImageJ software (National
Institutes of Health).
Quantitative Real-time PCR
Total RNA was isolated with the Trizol (Invitrogen) method,
and cDNA was synthesized with iScrip cDNA Synthesis Kit (Bio-
rad Laboratories) from 1 mg of total RNA. Real-time PCR was
performed with the cDNA samples and SYBR Green Supermix
(Bio-rad Laboratories) by using a Bio-Rad iCycler & iQ Real-
Time PCR Systems (Bio-rad Laboratories), and the formation of
PCR products was monitored by using the SYBR green method.
All samples were amplified in triplicate. The relative changes in
the amount of transcripts in each sample were determined by
normalizing with the 18S ribosomal RNA levels. The sequences of
the primers for Notch1 used in real-time PCR were as follows:
forward primer 59-GCAGTTGTGCTCCTGAAGAA-39; reverse
primer 59-CGGGCGGCCAGAAAC-39.
Double immunofluorescence staining
For double immunofluorescence staining, paraffin-embedded
tissues were cut into 4 mm sections, deparaffinized, rehydrated,
and then subjected to antigen retrieval. Tissue sections were
incubated with primary antibodies overnight at 4uC, followed by
incubation with secondary antibodies for 1 hour at room
temperature. The nuclei were counterstained for visualization
with 49, 6- diamidino-2-phenylindole. The primary antibodies
used were anti-Stro-1 (R&D Systems, Minneapolis, MN), anti-
CD34 (Cell Signaling Technology), anti-SM22-a (Abcam, Cam-
bridge, MA), anti-ER-TR7 (Santa Cruz Biotechnology), anti-
CD68 (Abcam), anti-Notch1 (Santa Cruz Biotechnology), anti-
activated Notch1 (Abcam), anti-Jagged1 (Santa Cruz Biotechnol-
ogy), anti-Delta (Santa Cruz Biotechnology), and anti-Hes1 (EMD
Millipore). Table 2 provides detailed information on the primary
antibodies. The secondary antibodies used were Alexa Fluor 488-,
Alexa Fluor 568-, and Alexa Fluor 647-conjugated anti-immuno-
globulin G (Invitrogen, Carlsbad, CA). Slides treated with normal
immunoglobulin G only were used as negative controls. Quanti-
fication of the staining results was performed by randomly
selecting 4 fields in each slide (n = 4 in each group), and counting
target cells at a magnification of6600 using the software Image-
Pro Plus 6.0 (Media Cybernetics, Bethesda, MD).
Table 1. Patient characteristics.a
Characteristics Control TAA TAD p
(n = 12) (n=14) (n =16) Values
Age (y) 59.168.2 64.865.5 63.865.6 0.07
Men 4 (33%) 6 (43%) 11 (69%) 0.1
History of smoking 6 (50%) 14 (100%) 12 (75%) 0.01
Hypertension 6 (50%) 13 (93%) 16 (100%) 0.001
Diabetes mellitus 4 (33%) 2 (14%) 1 (6%) 0.2
Taking anti-lipid medication 2 (17%) 5 (36%) 5 (31%) 0.5
Aortic diameter at sample site
(cm)
NA 6.460.9 6.361.3 0.9
aAge and aortic diameter were compared by using one-way analysis of variance.
All other variables were compared by using Pearson’s chi-squared test.
NA= not applicable; TAA= thoracic aortic aneurysm; TAD= thoracic aortic
dissection.
doi:10.1371/journal.pone.0052833.t001
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Statistical analysis
All quantitative data are presented as the mean 6 standard
deviation. Data were analyzed with SPSS software, version 11.0
(SPSS Inc, Chicago, IL). The differences among the 3 groups were
evaluated by Pearson’s chi-squared test for categorical variables
and by one-way analysis of variance for continuous variables.
Two-tailed probability values are reported.
Results
Overall activation of Notch signaling is increased in the
aortic wall of DTAAD patients
To examine the activation of Notch signaling in the aortic wall,
we performed western blots on the protein lysate from aortic
tissues. The level of the Notch1 protein (transmembrane/
intracellular region NTM, ,120 kDa) was significantly increased
in the aortic wall of TAA patients compared with control patients
(P = 0.009);the levels were higher in TAD patients than in controls,
but that difference did not reach statistical significance (P= 0.06)
(Fig. 1A). Although the full-length version of the Notch1 protein
(,300 kDa) was not detected via western blot, real-time RT-PCR
showed increased levels of Notch1 mRNA in TAA and TAD
tissues (Fig. 1B), indicating that the upregulation of Notch1 may be
at the transcriptional level. Additionally, NICD, the active form of
Notch, was barely detectable in the aortic tissue of controls but was
highly expressed in both TAA and TAD tissues (Fig. 1A).
Furthermore, Hes1, which is a downstream target of Notch
signaling, was also significantly increased in TAA and TAD
samples (Fig. 1C). Together, these findings indicate activation of
the Notch signaling pathway in TAA and TAD.
Notch signaling is downregulated in aortic medial VSMCs
of DTAAD patients
We examined the activation of Notch signaling in different types
of cells found within the aortic wall. First, we assessed Notch
signaling in medial VSMCs. Immunofluorescence double staining
experiments showed that both DLL1/4 Notch ligand and the
Notch1 receptor were significantly decreased in the VSMCs of
TAA and TAD tissues compared with control tissues (Fig. 2A, B).
The active NICD and the downstream target Hes1 were rarely
detected in medial VSMCs of TAA and TAD tissues (Fig. 2C, D),
indicating minimal activation of Notch signaling in these cells.
These findings suggest reduced production of the DLL1/4ligand
and the Notch1 receptor, along with decreased Notch signaling in
medial VSMCs in DTAAD tissue.
Notch signaling is activated in CD34+ stem cells and
Stro-1+ stem cells in DTAAD patients
We have previously shown that the number of stem cells was
increased in TAA and TAD tissues compared to normal aortic
tissue [22]. Because Notch signaling plays a critical role in stem
cell proliferation [9] and SMC differentiation [13], we examined
Notch activation in aortic stem cells. Double staining immunoflu-
orescence experiments showed that Jagged1 ligand, NICD, and
Hes1 were highly expressed in CD34+ stem cells (Fig. 3) and Stro-
1+ stem cells (Fig. 4) in aortas from TAA and TAD patients,
indicating activation of Notch signaling in these stem cells within
the injured aortic wall.
Notch signaling is activated in fibroblasts in DTAAD
patients
Fibroblasts can proliferate rapidly in response to injury and
contribute to tissue repair [23]. Furthermore, fibroblasts are
important in maintaining aortic tensile strength and preventing
aortic dilatation and rupture in response to aortic injury. Notch
signaling has been shown to be involved in fibroblast-mediated
tissue repair [24]. Thus, we examined changes in fibroblast levels
in the diseased [24] aortic wall and the activation of Notch
signaling in fibroblasts. Using ER-TR7 as a fibroblast marker, we
detected significantly more fibroblasts in the adventitia of TAA
and TAD tissues than in control tissue (P,0.001) (Fig. 5).
Additionally, NICD was detected in most aortic fibroblasts in
TAA and TAD tissues (35.2% in control; 69.2% in TAA
[P= 0.009 vs. control]; 65.5% in TAD [P= 0.02 vs. control])
Table 2. Primary antibodies used in the study.
Antibody Source Host Specificity Application
Anti-cleaved Notch1 (D3B8) 4147 Cell Signaling Rabbit Cleaved Notch1 intracellular domain (NICD)
(,110 kDa)
WB
Anti-Notch1 (D6F11) 4380 Cell Signaling Rabbit Full-length (,300 kDa) and the
transmembrane/intracellular region NTM
(,120 kDa)
WB
Anti-Stro-1 MAB1038 R&D Mouse Human Stro-1 IF
Anti-CD34 (ICO115) 3569 Cell Signaling Mouse Total CD34 protein IF
Anti-SM22-a ab14106 abcam Rabbit SM22-a IF
Anti-SM22-a ab10135 abcam Goat SM22-a IF
Anti-ER-TR7 sc-73355 Santa Cruz Rat Fibroblasts IF
Anti-CD68 ab955 Abcam Mouse Macrophage antigen CD68 IF
Anti-Notch1 (C-20) sc-6014 Santa Cruz Goat C-terminus of Notch 1 IF
Anti-activated Notch1 ab8925 Abcam Rabbit Cleaved Notch1 intracellular domain (NICD) IF
Anti-Jagged1 (C-20) sc-6011 Santa Cruz Goat Jagged1 IF
Anti-Delta (C-20) sc-8155 Santa Cruz Goat Delta-like 1 and Dleta-like 4 (DLL1/4) IF
Anti-Hes1 AB5702 Millipore Rabbit Hes-1 IHC, IF
WB=western blot; IF = immunofluorescence staining; IHC = immunohistochemistry.
doi:10.1371/journal.pone.0052833.t002
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(Fig. 5A); Hes1 was also highly expressed in most fibroblasts
(Fig. 5B). These findings indicate the activation of Notch signaling
in fibroblasts of the aortic wall in DTAAD patients.
Notch signaling is activated in macrophages in DTAAD
patients
Macrophages have been shown to play a critical role in aortic
destruction and AAD development [25,26]. Moreover, Notch1
positively regulates IL-6 expression in activated macrophages [26].
Thus, we examined Notch activation in macrophages in TAA and
TAD. Using CD68 as the marker for macrophages, we found
significantly more macrophages in the aortic wall in TAA and
TAD tissues than in control tissue (P,0.001). Moreover, NICD
was detected in most macrophages in TAA and TAD tissues
(35.8% in control; 70.4% in TAA [P,0.001 vs. control]; 77.2% in
TAD [P,0.001 vs. control]) (Fig. 6). Furthermore, Hes1 was also
expressed by most macrophages (Fig. 6B). These results suggest
activation of the Notch signaling pathway in macrophages of the
aortic wall in TAA and TAD patients.
Discussion
The Notch signaling pathway is a versatile regulator of cell
growth and differentiation [27,28,29], as well as cardiovascular
development [5,6] and repair [30]. In this study, we have shown a
complex pattern of Notch signaling in the aortic tissue of patients
Figure 1. Overall activation of Notch signaling is increased in the aortic wall of DTAAD patients. A) Western blot studies showed that the
expression of Notch1 (transmembrane/intracellular region NTM,,120 kDa) in human aortic tissue was significantly increased in TAA tissue compared
with control tissue, and NICD was significantly increased in TAA and TAD samples compared with control. B) Quantitative real-time RT-PCR showed
increased expression levels of Notch1 in TAA and TAD samples compared with control. C) Western blot studies showed that the expression of Hes1 in
human aortic tissue was significantly increased in TAA and TAD samples compared with control.
doi:10.1371/journal.pone.0052833.g001
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with DTAAD. Specifically, the Notch signaling pathway was
downregulated in medial VSMCs but activated in CD34+ stem
cells, Stro-1+ stem cells, fibroblasts, and macrophages. Our
findings suggest that impaired Notch signaling in VSMCs may
contribute to the apoptosis and depletion of VSMCs that
characterize DTAAD. The activation of Notch signaling in Stro-
1+ stem cells, CD34+ stem cells, and fibroblasts indicates a
potential role of Notch signaling in the regenerative response and
remodeling process in the aortic wall. In contrast, activation of
Notch signaling in macrophages suggests a role for Notch signaling
Figure 2. Notch signaling is downregulated in aortic medial VSMCs in DTAAD patients. A) Immunofluorescence double staining showed
that DLL1/4 in VSMCs of the aortic media was significantly decreased in both TAA and TAD tissues compared with control tissue. B) Notch1 in VSMCs
of the aortic media was significantly decreased in both TAA and TAD tissues compared with control tissue (scale bar = 25 mm, insets 6.25 mm). C) NICD
was rarely detected in vascular smooth muscle cells (VSMCs) of the aortic media in TAA and TAD tissues. D) Hes1 was rarely detected in VSMCs of the
aortic media in TAA and TAD tissues (scale bar = 50 mm).
doi:10.1371/journal.pone.0052833.g002
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in aortic inflammation during DTAAD formation and progres-
sion.
Although our study showed increased overall activation of
Notch signaling in the aortic wall of DTAAD patients, we found
that Notch signaling was significantly downregulated in medial
VSMCs. As the main cell type in the aortic media, VSMCs are
critical for maintaining aortic structure and function. Apoptosis
and depletion of VSMCs are common features of AAD [31].
Deficient repair or replacement of damaged VSMCs may lead to
impaired aortic healing and AAD formation. Notch signaling has
been shown to promote aortic SMC proliferation and inhibit
apoptosis [27]. Furthermore, it is well known that Notch signaling
promotes VSMC differentiation [28,32,33] and regulates SMC
functions [34,35] by inducing various SMC genes. Thus,
significant downregulation of Notch signaling in medial SMCs
may be partially responsible for the SMC apoptosis, insufficient
SMC repair, SMC depletion, and medial degeneration in AAD.
Multipotent stem cells play an important role in arterial repair
and remodeling after injury. Circulating endothelial progenitor
cells have been reported in a murine model of AAA [36] and in
patients with AAA [37] or ascending aortic aneurysms [37,38]. In
a previous study, we showed that Stro-1+ and CD34+ stem cells
were abundant in DTAAD [22]. Stem cell proliferation and
differentiation into SMCs may be critical for aortic repair. Notch
signaling has been shown to promote stem cell proliferation [9,39].
Furthermore, upregulation of Jagged1 (and thus Notch activation)
appears to be involved in the differentiation of stem cells along the
SMC lineage [13]. In the present study, we found that Notch
signaling was activated, and the Notch ligand Jagged1 was highly
expressed in stem cells. Therefore, it is possible that activation of
Figure 3. Notch signaling is activated in CD34+ stem cells in DTAAD patients. A) Immunofluorescence double staining showed that
Jagged1 was expressed in CD34+ stem cells in the aortic media of both TAA and TAD tissues. B) Immunofluorescence double staining showed that
NICD was highly expressed in CD34+ stem cells in the aortic media of both TAA and TAD tissues (scale bar = 25 mm). C) Immunofluorescence double
staining showed that Hes1 was highly expressed in CD34+ stem cells in the aortic wall of both TAA and TAD tissues (scale bar = 50 mm).
doi:10.1371/journal.pone.0052833.g003
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the Notch signaling pathway in Stro-1+ and CD34+ stem cells
facilitates stem cell proliferation and differentiation into SMCs,
contributing to aortic repair in DTAAD; further studies are
needed to examine this potential mechanism.
Fibroblasts are important components of the aortic wall and may
play diverse roles in aortic repair, remodeling, and inflammation, but
the role of fibroblasts in the pathogenesis and development of AAD is
poorly understood. In the present study, we observed large numbers
of fibroblasts in the aortic wall of DTAAD patients. Because
fibroblasts can proliferate rapidly in response to injury and thus help
significantly in cardiovascular repair [23,24,40], our finding of large
numbers of fibroblasts may represent a response to aortic injury; this
response may be an attempt to help maintain aortic strength and
prevent aortic dilatation and rupture. However, uncontrolled
proliferation of fibroblasts promotes fibrotic remolding [41] with
decreased contractile function and compliance. Additionally, fibro-
blasts produce cytokines and monocyte chemotactic protein-1 [42]
and promote inflammatory cell recruitment/activation and aortic
inflammation, all of which cause further tissue damage. Thus, proper
control of fibroblast homeostasis in the aortic wall is critical. Notch
signaling induces fibroblast proliferation [24], and in the present
study, we observed high levels of NICD and Hes1 in most fibroblasts
in TAA and TAD tissues, indicating the activation of Notch
signaling. This activation may contribute to fibroblast proliferation.
Further studies are required to define the role of fibroblasts in aortic
remodeling during AAD formation and progression and to identify
how Notch signaling regulates the process.
Macrophages play a destructive role in AAD formation and
progression. Previous studies have shown that AAA expansion is
associated with macrophage accumulation in regions of medial
Figure 4. Notch signaling is activated in Stro-1+ stem cells in DTAAD patients. A) Immunofluorescence double staining showed that
Jagged1 was expressed in Stro-1+ stem cells in the aortic media of both TAA and TAD tissues. B) Immunofluorescence double staining showed that
NICD was highly expressed in Stro-1+ stem cells in the aortic media of both TAA and TAD tissues (scale bar = 25 mm). C) Immunofluorescence double
staining showed that Hes1 was highly expressed in Stro-1+ stem cells in the aortic wall of both TAA and TAD tissues (scale bar = 50 mm).
doi:10.1371/journal.pone.0052833.g004
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disruption, predominantly on the adventitial aspect [43]. More-
over, macrophage-mediated vascular inflammation can lead to
aortic dissection [42] and contributes to aortic aneurysm
formation [44]. In addition, macrophages are the major source
of protease activity in aneurysmal tissues [25] and produce pro-
inflammatory cytokines such as IL-6 [26]. In our study, we found
significantly more macrophages in the aortic wall of TAA and
TAD tissue than in control aortic tissue, and both NICD and Hes1
were detected in most macrophages; these findings indicate that
Notch signaling is activated in macrophages. It was recently
reported that inflammatory macrophage polarization was pro-
moted by transcription factor IRF8, which is regulated by Notch
signaling [45], and the activation of Notch signaling in macro-
phages positively regulates IL-6 expression via NF-kB [26].
Furthermore, blocking the Notch signaling pathway inhibits
vascular inflammation in large-vessel vasculitis [46]. Thus, we
speculate that the activation of Notch signaling in macrophages of
DTAAD tissue contributes to aortic inflammation and plays a
destructive role in DTAAD formation and progression.
In our study, the total levels of Notch1, NICD, and Hes1 were
increased in the aortas of DTAAD patients. Although Notch
signaling was downregulated in medial VSMCs, it was activated in
CD34+, Stro-1+ stem cells, CD68+ macrophages, and EN-TR7+
fibroblasts. Because the number of these types of cells is
significantly increased in DTAAD compared with control tissues,
the significant activation of Notch signaling in these cell
populations may be responsible for the overall upregulation of
Notch signaling in the aorta of DTAAD patients.
Figure 5. Notch signaling is activated in fibroblasts in DTAAD patients. A) ER-TR7 was used as the marker for fibroblasts in
immunofluorescence double staining experiments. Significantly more fibroblasts were seen in the adventitia of the aortic wall of TAA and TAD tissues
than in control tissue (TAA vs. control, P,0.001; TAD vs. control, P,0.001), and NICD was detected in most fibroblasts in TAA and TAD tissues (TAA vs.
control, P = 0.009; TAD vs. control, P = 0.02) (scale bar = 25 mm, insets 6.25 mm). Error bars indicate the standard deviation in the number of NICD+
fibroblasts. B) Immunofluorescence double staining showed that Hes1 was highly expressed in fibroblasts in the aortic wall of both TAA and TAD
tissues (scale bar = 50 mm).
doi:10.1371/journal.pone.0052833.g005
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Given the differences in the pathobiology of aneurysmal disease
in a given segment of the aorta, it is unclear whether Notch
signaling will show similar patterns of disease occurring in the
ascending aorta, descending thoracic aorta, and abdominal aorta.
It was recently reported that expression of NOTCH3 mRNA was
decreased in human AAA tissue when compared with control
tissue samples from significantly younger organ donors (AAA
patients, 71.567.5 years; donors, 42.7612.5 years) [19]. Notch
signaling was also found to be decreased in ascending aortas from
patients with BAV, which increases the risk of premature death
and of developing AAD, compared with patients who have a
normal trileaflet aortic valve (TAV) [20]. Furthermore, genetic
variation in NOTCH1 appears to confer susceptibility to ascending
aortic aneurysm formation in patients with BAV but not in
patients with TAV [21]. Thus, altered Notch signaling may play a
critical role in the development of AAD.
This study has several important limitations. First, it is a
descriptive study, and the role of Notch signaling in aortic
remodeling remains to be determined by additional studies.
Second, the samples we examined represent end-stage disease, so
we were unable to study the activation of Notch signaling during
the early stages of DTAAD formation. Third, we observed
significant variation in Notch levels, reflecting the heterogeneity of
pathogenesis and disease progression in aortic tissue.
In conclusion, the Notch signaling pathway was downregulated
in medial VSMCs but activated in CD34+ stem cells, Stro-1+ stem
cells, fibroblasts, and macrophages. Further studies are required to
determine the role of Notch signaling in each cell type and how the
Figure 6. Notch signaling is activated in macrophages in DTAAD. A) CD68 was used as the marker for macrophages in immunofluorescence
double staining experiments. Significantly more macrophages were seen in the aortic wall of TAA and TAD tissues compared with control tissue (TAA
vs. control, P,0.001; TAD vs. control, P,0.001), and NICD was detected in most macrophages in TAA and TAD tissues (TAA vs. control, P,0.001; TAD
vs. control, P,0.001) (scale bar = 25 mm, insets 6.25 mm). Error bars indicate the standard deviation in the number of NICD+macrophages. B)
Immunofluorescence double staining showed that Hes1 was highly expressed in macrophages in the aortic wall of both TAA and TAD tissues (scale
bar = 50 mm).
doi:10.1371/journal.pone.0052833.g006
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pathway is regulated. Moreover, understanding how to selectively
regulate Notch signaling (ie, stimulate it in SMCs and inhibit it in
inflammatory cells) may promote Notch-mediated aortic repair and
reduce Notch-mediated aortic inflammation. This information may
be useful in developing new treatment strategies for AAD.
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